Article | January 18, 2022

How DCTs Differ Across The Clinical Trial Landscape

Source: Encapsia
doctor meeting clinical iStock-846002754

The message was clear from industry leaders last year – today’s clinical trials need decentralized solutions. More complexity means intensive data capture and continuous flows are essential, and vital strategic decisions rely on real-time data analysis and intelligence. 

Existing point and unified solutions cannot fully meet the challenges and adapt to this dynamic world of decentralized trials, digital transformation, and data science.

Whether virtually or in-person, leaders emphasized that a holistic clinical technology platform is essential to enable decentralized clinical trials (DCT) today. Based upon the organization, clinical portfolio, and outsourcing model, DCT will look like many different things across the clinical trials landscape.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader